Sped Pharma Private Limited
About Sped Pharma Private Limited
Data last updated:
Sped Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 19 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2016PTC291471. Its GSTIN is 07AAWCS7970A1ZV (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Alpana Deb and Subhro Deb.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F 1126 F/F Chittranjan Park, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.97 Lakh, a decline of 5% compared to the previous year. For the same year it recorded a net loss of ₹3.95 Lakh (net margin -133.2%) and EBITDA of -₹3.95 Lakh (EBITDA margin -133.2%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sped Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressF 1126 F/F Chittranjan Park, New Delhi, Delhi, India – 110019
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Sped Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sped Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Sped Pharma Private Limited, buy the company report.
Financials of Sped Pharma Private Limited
FY 2025 filings availableSped Pharma Private Limited reported revenue of ₹2.97 Lakh (down 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 5% fall in the latest year. EBITDA fell 850% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.95 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.95 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -133.2% | ||||
| Net Profit Margin | -133.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sped Pharma Private Limited, buy the company report.
Board of directors of Sped Pharma Private Limited
Sped Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alpana Deb | Director | 19 Feb 2016 | 10 Years 8 Months | Current |
| Subhro Deb | Director | 19 Feb 2016 | 10 Years 8 Months | Current |
| Saurabh Bansal | Director | 19 Feb 2016 | 10 Years 8 Months | Current |
Peer comparison
Sped Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ock Industries Private Limited | ₹2.97 Lakh (FY 2020) | Howrah, West Bengal, India | ||||
| Dhanurdharini Broking Advisors Limited | ₹2.97 Lakh (FY 2024) | 5.0% | Kolkata, West Bengal, India | |||
| Reverie Studio Private Limited | ₹2.97 Lakh (FY 2025) | -47.0% | Ahmedabad, Gujarat, India | |||
| Ezee Pay Services Private Limited | ₹2.97 Lakh (FY 2024) | -82.0% | Chennai, Tamil Nadu, India | |||
| Winv Electronics Private Limited | ₹2.97 Lakh (FY 2023) | 47.0% | Chennai, Tamil Nadu, India | |||
| Sped Pharma Private Limitedthis company | ₹2.97 Lakh (FY 2024) | -₹3.95 Lakh | -133.2% | -5.0% | New Delhi, Delhi, India | |
| Mrnmrs Ekart Retail Trading Private Limited | ₹2.97 Lakh (FY 2019) | Bijnor, Uttar Pradesh, India | ||||
| Future India Led Private Limited | ₹2.97 Lakh (FY 2017) | Banka, Bihar, India | ||||
| Makenovate Industries Private Limited | ₹2.96 Lakh (FY 2025) | 818.0% | Vadamukhawadi, Maharashtra, India | |||
| Makrely Power and Energy Private Limited | ₹2.96 Lakh (FY 2023) | -89.0% | Delhi, India | |||
| Azotus Educational Research Private Limited | ₹2.96 Lakh (FY 2024) | -36.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Sped Pharma Private Limited, buy the company report.
Auditor
Sped Pharma Private Limited is audited by ADISHJAIN for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ADISHJAIN | FY 2017 | 515436 |
Shareholding
The shareholding of Sped Pharma Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Sped Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sped Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sped Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sped Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAWCS7970A1ZV | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sped Pharma Private Limited, buy the company report.
Recent activity
Sped Pharma Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Satish Singh ceased to be Director on 13 Aug 2018.
Frequently asked questions
Sped Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 19 February 2016 (10+ years old) and is registered under CIN U24230DL2016PTC291471.
Sped Pharma has 3 current directors:
- Alpana Deb - Director
- Subhro Deb - Director
- Saurabh Bansal - Director
The latest financial statements of Sped Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Sped Pharma is 07AAWCS7970A1ZV, registered in Delhi.
The CIN (Corporate Identification Number) of Sped Pharma is U24230DL2016PTC291471. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sped Pharma was incorporated on 19 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sped Pharma by revenue are Ock Industries Private Limited, Dhanurdharini Broking Advisors Limited, Reverie Studio Private Limited, Ezee Pay Services Private Limited, Winv Electronics Private Limited and 5 more, all in the same principal business activity (retail trading).
Satish Singh ceased to be Director on 13 Aug 2018. Alpana Deb was appointed as Director on 19 Feb 2016. Saurabh Bansal was appointed as Director on 19 Feb 2016. Sped Pharma has 4 board changes on record in total.
The registered office of Sped Pharma is at F 1126 FF Chittranjan Park, New Delhi, Delhi, India – 110019.
Sped Pharma operates in the trading industry, in the wholesale segment.
The compliance status of Sped Pharma is compliant as of 07 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
